» Articles » PMID: 10827002

Somatostatin Restrains the Secretion of Glucagon-like Peptide-1 and -2 from Isolated Perfused Porcine Ileum

Overview
Date 2000 May 29
PMID 10827002
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Suspecting that paracrine inhibition might influence neuronal regulation of the endocrine L cells, we studied the role of somatostatin (SS) in the regulation of the secretion of the proglucagon-derived hormones glucagon-like peptide-1 and -2 (GLP-1 and GLP-2). This was examined using the isolated perfused porcine ileum stimulated with acetylcholine (ACh, 10(-6) M), neuromedin C (NC, 10(-8) M), and electrical nerve stimulation (NS) with or without alpha-adrenergic blockade (phentolamine 10(-5) M), and perfusion with a high-affinity monoclonal antibody against SS. ACh and NC significantly increased GLP secretion, whereas NS had little effect. SS immunoneutralization increased GLP secretion eight- to ninefold but had little influence on the GLP responses to ACh, NC, and NS. Basal SS secretion (mainly SS28) was unaffected by NS alone. Phentolamine + NS and NC abstract strongly stimulated release mainly of SS14, whereas ACh had little effect. Infused intravascularly, SS14 weakly and SS28 strongly inhibited GLP secretion. We conclude that GLP secretion is tonically inhibited by a local release of SS28 from epithelial paracrine cells, whereas SS14, supposedly derived from enteric neurons, only weakly influences GLP secretion.

Citing Articles

The emerging role of gut hormones.

Cho H, Lim J Mol Cells. 2024; 47(11):100126.

PMID: 39426686 PMC: 11577206. DOI: 10.1016/j.mocell.2024.100126.


Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy.

Habib S World J Gastrointest Pathophysiol. 2024; 15(4):93606.

PMID: 39220834 PMC: 11362842. DOI: 10.4291/wjgp.v15.i4.93606.


Inhibition of somatostatin enhances the long-term metabolic outcomes of sleeve gastrectomy in mice.

Kleiman D, Arad Y, Azulai S, Baker A, Bergel M, Elad A Mol Metab. 2024; 86:101979.

PMID: 38945296 PMC: 11278880. DOI: 10.1016/j.molmet.2024.101979.


Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month....

Stefanakis K, Kokkinos A, Argyrakopoulou G, Konstantinidou S, Simati S, Kouvari M Diabetes Obes Metab. 2023; 25(9):2561-2574.

PMID: 37246799 PMC: 10524619. DOI: 10.1111/dom.15141.


How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients.

Zaina A, Prencipe N, Golden E, Berton A, Arad E, Abid A Endocrine. 2023; 80(3):491-499.

PMID: 37000406 DOI: 10.1007/s12020-023-03352-4.